A greater understanding of neural mechanisms contributing to anxiety is needed in order to develop better therapeutic interventions. This study interrogates a novel molecular mechanism that shapes anxiety-like behaviour, demonstrating that the microRNA miR-101a-3p and its target, enhancer of zeste homolog 2 (Ezh2) in the amygdala, contribute to rodent anxiety-like behaviour. We utilized rats that were selectively bred for differences in emotionality and stress reactivity, showing that high-novelty-responding (HR) rats, which display low trait anxiety, have lower miR-101a-3p levels in the amygdala compared to low-novelty-responding (LR) rats that characteristically display high trait anxiety. To determine whether there is a causal relationship between amygdalar miR101a-3p and anxiety behaviour, we used a viral approach to overexpress miR-101a-3p in the amygdala of HR rats and test whether it would increase their typically low levels of anxiety-like behaviour. We found that increasing miR-101a-3p in the amygdala increased HRs' anxiety-like behaviour in the open-field test and elevated plus maze. Viral-mediated miR-101a-3p overexpression also reduced expression of the histone methyltransferase Ezh2, which mediates gene silencing via trimethylation of histone 3 at lysine 27 (H3K27me3). Knockdown of Ezh2 with short-interfering RNA (siRNA) also increased HRs' anxiety-like behaviour, but to a lesser degree than miR-101a-3p overexpression. Overall, our data demonstrate that increasing miR-101a-3p expression in the amygdala increases anxiety-like behaviour and that this effect is at least partially mediated via repression of Ezh2. This work adds to the growing body of evidence implicating miRNAs and epigenetic regulation as molecular mediators of anxiety behaviour.
Introduction
Anxiety disorders are characterized by excessive fear and anxiety and are both highly prevalent, with a lifetime risk for developing any anxiety disorder estimated at 28.8% in the U.S., and can cause lifelong impairment in many patients (Kessler et al., 2008) . A greater understanding of the molecular mechanisms that contribute to anxiety is needed in order to develop more effective treatments. In order to elucidate genetic and environmental factors that produce an anxious phenotype, we developed a rat model of individual differences in emotionality by selectively breeding Sprague Dawley rats for disparate response to novelty (Stead et al., 2006) . Rats bred for high response to novelty (HRs) vigorously explore new environments and exhibit low levels of trait anxiety compared to rats bred for low response to novelty (LRs), which exhibit high levels of trait anxiety (Clinton et al., 2011; Cohen et al., 2015; Glover et al., 2015) .
Previous work from our group suggests that HR/LR differences in anxiety-like behaviour rely, in part, on differences in the amygdala (Cohen et al., , 2016 . The amygdala has been recognized for its role in anxiety and fear behaviour for nearly a century (Kluver & Bucy, 1938; Weiskrantz & Mishkin, 1958) . The amygdala is critical for encoding the emotional valance of stimuli and is activated while viewing fearful, angry or happy faces (Breiter et al., 1996; Fitzgerald et al., 2006) . Dysregulation of amygdalar activity has been implicated in numerous anxiety disorders (Rauch et al., 2003) . Hyperactivity in the amygdala in response to stressful or fear-inducing stimuli has been shown in patients with generalized anxiety disorder (Fonzo et al., 2014; Mochcovitch et al., 2014) , social anxiety disorder (Kim et al., 2011; Young et al., 2017) and post-traumatic stress disorder (Nuss, 2015; Patel et al., 2016) . We recently found that low-anxiety HR rats display reduced c-Fos activation in multiple amygdalar subnuclei following electric shock stress compared to LRs. We then used high-throughput sequencing of mRNAs and microRNAs (miRNAs) in the HR/LR amygdala to begin to interrogate molecular mechanisms that may drive their disparate behavioural and neural responses to stress (Cohen et al., 2016) . miRNAs are short non-coding RNAs that control translation and/or stability of mRNA targets. Each miRNA potentially targets several genes, so co-expression of only a few miRNAs exerts powerful control over large gene networks (Mathonnet et al., 2007; Brodersen & Voinnet, 2009) . miRNAs are increasingly recognized for their role in human mental illness (O'Connor et al., 2012; Hauberg et al., 2016) . Single nucleotide polymorphisms associated with several miRNAs effect risk for anxiety disorders (Muinos-Gimeno et al., 2011; Hommers et al., 2015) , and expression levels of other miRNAs have been shown to correlate with anxiety symptoms (Xu et al., 2016) . Rodent studies show that acute and chronic stress affect miRNA expression (Meerson et al., 2010; Rinaldi et al., 2010) , and rats that are vulnerable vs. resilient to developing learned helpless behaviour display baseline miRNA expression differences (Smalheiser et al., 2011) . Several miRNA knockout mice display alterations in anxiety-like behaviour (Andolina et al., 2016; Jin et al., 2016) . Most work examining behavioural effects of amygdalar miRNA focuses on fear learning (Volk et al., 2014) . For example, inhibiting miR-34a in the basolateral amygdala inhibits cued fear learning by disinhibiting Notch1 signalling (Dias et al., 2014) , although overexpressing amygdalar miR-144-3p (which also targets Notch1) enhances fear extinction (Murphy et al., 2016) . While a picture of the role of amygdalar miRNAs in mediating behavioural changes in response to environmental stimuli (i.e. cued fear or stress) is beginning to emerge, relatively little is known of how miRNAs may influence individual differences in trait anxiety. The selectively bred HR/LR lines can be used to interrogate these questions.
Our recent transcriptome study identified miR-101a-3p as one of the most abundant miRNAs in the amygdala and showed that HR rats had significantly lower miR-101a-3p levels in the amygdala relative to LRs (Cohen et al., 2016) . A major target miR-101a-3p is the polycomb repressive complex 2 (PRC2), a multiprotein complex including histone methyltransferase enhancer of zeste homolog 2 (Ezh2; Varambally et al., 2008; Friedman et al., 2009) , which mediates gene silencing via trimethylation of histone 3 at lysine 27 (H3K27me3; Cao et al., 2002; Marchesi & Bagella, 2013) . PRC2 critically regulates gene expression during several developmental processes (Marchesi et al., 2014) , including formation of brain circuits (Di Meglio et al., 2013; Neo et al., 2014) , although a fairly limited number of studies have examined Ezh2 and H3K27me3 in the adult brain (Qi et al., 2014; Zhang et al., 2014; Koo et al., 2015) .
The present study builds on our previous findings by measuring Ezh2 and H3K27me3 levels in the amygdala of HR/LR rats (to test whether HR/LR miR-101a expression differences are associated with predicted changes in these targets) and determining whether manipulating amygdalar miR-101a-3p and Ezh2 expression can alter anxiety-like behaviour. Because we found significantly lower miR101a-3p levels in the HR vs. LR amygdala and because miR-101a-3p represses PRC2 signalling, we hypothesized (i) that HRs would exhibit elevated Ezh2 and H3K27me3 levels in the amygdala relative to LRs, and (ii) that increasing miR-101a-3p expression in the HR amygdala would increase their anxiety-like behaviour through repression of Ezh2 and H3K27me3.
Methods
All experiments were approved by the Institutional Animal Care and Use Committee at the University of Alabama at Birmingham and conducted in accordance with National Institutes of Health guidelines on animal care and experimentation.
Animals
Adult male HR/LR rats were obtained from the 8th generations of our in-house colony (McCoy et al., 2016) . Rats were pair-housed in a 12 : 12 light-dark cycle in a temperature-and humidity-controlled environment with food and water available ad libitum.
Viral constructs
Adeno-associated viruses (AAVs) engineered to express either premiR-101a and GFP or only GFP were created by the University of Alabama at Birmingham, Neuroscience NINDS Protein Interactions Core C. Pre-miR-101a was cloned downstream of GFP in the pSLIK series of vectors, MBA253 digested with BfuAI (ATCC; Shin et al., 2006) and ligated with annealed primers to miR-101a (primers designed based on miRBase Accession Number: MI0000886) with overlapping BfuAI sites (miR-101a-F: 5 0 -agcgaTGCCCTGGCTCAGTTATCAC AGTGCTGATGCTGTCCATTCTAAAGGTACAGTACTGTGATAA CTGAAGGATGGCAC and miR-101a-R: 5 0 -ggcagTGCCATCCTTC AGTTATCACAGTACTGTACCTTTAGAATGGACAGCATCAGCA CTGTGATAACTGAGCCAGGGCAT). The resulting MBA253-premiR-101a clone was amplified by PCR to include the GFP provided by the MBA253 vector [miR-101a-GFP-F: 5 0 -AAGCTTggatccGCCG CCACCATGGTGAGCAAGGGCGAG; mir101a-GFP-R: gatatcagatct AATTGAAAAAAGTGATTTAATTTATACC]. It was cloned into the BamHI and BglII sites of AAV-MCS (Agilent, Santa Clara, CA, USA) to obtain the AAV-GFP-miR-101a vector; the clones obtained were in reverse orientation due to the compatibility of the BamHI and BglII overhangs. The vector was digested with BamHI and XbaI, and thẽ 1100 bp GFP-miR-101a fragment was subcloned into the BamHI and XbaI sites of AAV-MCS (Agilent) to achieve proper orientation with respect to the promoter. pAAV-GFP vector was obtained from Agilent. All clones were verified by sequencing.
For AAV production, 293A cells (Agilent) were transfected using calcium phosphate transfection (Clontech. Mountain View, CA, USA) with 10 lg each of pAAV-RC, pAAV-Helper, and AAV-GFP-miR-101a or pAAV-GFP. After 72 h, the transfected cells were harvested, pelleted, resuspended in serum-free DMEM and subjected to four rounds of freeze/thaw cycles. The AAV-containing supernatants were spun at 10 000 9 g for 10 min to pellet cell debris and viral supernatants were stored at À80°C. The AAVs were purified using columns according to the manufacturer's instructions (Cell Biolabs, San Diego, CA, USA), which included final buffer exchange and concentration. AAV-GFP-pre-miR-101a (referred to henceforth as AAV-miR-101a) and AAV-GFP were tittered by infectivity on HT1080 cells (ATCC; 1.5 9 10 8 AAV-miR-101a and 1.2 9 10 8 AAV-GFP infectious units/mL) and by RT-PCR (5.3 9 10 11 AAV-miR-101a and 5.2 9 10 11 AAV-GFP genome copies/mL).
Intracranial surgeries to manipulate miR-101a or Ezh2 expression
Intracranial surgeries were performed on 71 HR male rats (60-75 days old) as described previously (Nam & Kerman, 2016) . One group of rats (n = 33) were used in an experiment to overexpress miR-101a via AAV viral infusion in the amygdala; the second group (n = 48) was used in an experiment to suppress Ezh2 expression via short-interfering RNA (siRNA) infusion. Rats were anesthetized with a mixture of oxygen (1 L/min) and isoflurane (5% for induction, and 1-3% for maintenance). Following administration of carprofen (5 mg/kg sc; Pfizer Inc., New York, NY, USA) and buprenorphine (0.05-0.1 mg/kg sc; Reckitt Benckiser Pharmaceuticals, Richmond, VA, USA) for post-surgical analgesia, rats were secured in a stereotaxic frame using blunt ear bars. Skin over the skull was shaved, sterilized and incised. Bregma and lambda were identified to determine stereotaxic coordinates using Angle Two software (Leica Biosystems, Richmond, IL, USA). The coordinates A/P: À2.8, M/L: AE4.8 and D/V: À8.43 were used to target the left and right amygdala, respectively. Both left and right amygdala were injected with either 1 lL AAV-miR-101a (n = 18; 5.3 9 10 11 genome copies/mL) or AAV-GFP (n = 15; 5.2 9 10 11 genome copies/ mL) for the miR-101a overexpression experiment or 1 lL Ezh2 siRNA (n = 26; 15 lM; GE Dharmacon, Lafayette, CO, USA) or control siRNA (n = 22; 15 lM) over 5 min. After injections, the overlying skin was sutured. Rats were returned to their home cages upon full recovery from anaesthesia.
Animals in the miR-101a overexpression experiment were given 2 weeks to allow for surgical recovery and because expression of viral genes requires 2 weeks to reach peak levels in neurons (Mason et al., 2010) . Animals in the Ezh2 siRNA experiment were given 7 days to recover because siRNA-induced knockdown is achieved within 2-3 days (Nakajima et al., 2012) . After each of these recovery periods, all animals were subjected to 2 days of behavioural testing.
Behavioural testing
All behaviours were recorded using a computerized analysis program (Ethovision XT 8.0, Noldus, Wageningen, the Netherlands), and all testings were conducted under dim light (30 lux) between 8:00 and 1:00 pm. Animals were tested first on the open-field test (OFT) followed by the elevated plus maze (EPM) 24 h later.
Open-field test
The OFT was conducted in a 100 9 100 9 50 cm black Plexiglas box with a black floor as described . At the beginning of the test, a rat was placed in a corner of the box and was permitted to explore the apparatus for 5 min. The latency to enter the centre of the OF, the amount of time spent and distance travelled in the centre, sides and corners of the apparatus were quantified. The periphery was defined by a 20-cm zone around the edge of the OF arena that was further subsided into mutually exclusive side (20 9 60 cm) and corner (20 9 20 cm) zones.
Elevated plus maze
The EPM test was conducted as described 
Tissue collection and molecular analyses
For HR/LR comparisons, 75-day-old male rats were killed (n = 12/ phenotype) by decapitation, brains were removed, flash frozen and stored at À80°C until further processing. For the miR-101a overexpression and Ezh2 siRNA experiments, all animals were killed in the same manner 24 h following the last behavioural test.
RNA extraction
Amygdala samples were dissected, and RNA was extracted using the miRNeasy Mini Kit (Qiagen, Germantown, MD, USA). cDNA was created using the miScript RT Kit II (Qiagen) and stored at À20°C until processing for quantitative real-time PCR (qRT-PCR).
Protein extractions
Whole-cell protein extractions were performed on amygdala samples in RIPA lysis buffer, quantified by BSA assay (Thermo Scientific, Waltham, MA) and stored at À80°C until processing for Western blot.
Quantitative real-time PCR
cDNA was used for qRT-PCR as described (Clinton et al., 2011) on a StepOne Plus (Applied Biosystems, Grand Island, NY, USA). Primers for the mRNAs Ezh2 (F-GGAGACGATCCTGATGAAAGAG; R-C TTCTGCTGTGCCCTTATCT), Gapdh (F-ACCTTTGATGCTGGG GCTGGC; R-GGGCTGAGTTGGGATGGGGACT) and GFP (F-A TGGTGAGCAAGGGCGAGGA; R-TTTACGTCGCCGTCCAGCTC GA) were purchased from Integrated DNA Technologies (Coralville, Iowa, USA). Primers for the small RNAs rno-miR-101a-3p (Ca. #: MS00012950), rno-miR-101a-5p (Ca, #: MS00012957), pre-miR-101a (Ca. #: MP00006993) and Snord61 (Ca. #: MS00033705) were ordered from Qiagen.
Western blot
Protein fractions were added to Laemmli sample buffer and loaded onto SDS-PAGE gels (4-20% acrylamide and 12% acrylamide for histones; Bio-Rad, Hercules, CA, USA) for protein gel electrophoresis. Immunoblots were later incubated in primary antibodies overnight at 4°C followed by 1-h incubation with secondary antibodies and visualization on an Odyssey Infrared Imaging System (LI-COR). Following imaging, blots were put in a stripping buffer if necessary (1 : 50 NaOH) for 10 min and re-blocked prior to incubation with the primary antibody for the housekeeping protein (actin or histone H3) for 2 h. Secondary antibody incubation and imaging were performed in the same manner. The following primary antibodies (all of rabbit host) were used: anti-H3K27me3 (1 : 4000; Millipore #07-449), anti-histone H3 (1 : 4000; Abcam #ab1791), anti-Ezh2 (1 : 2000; Abcam #ab3748) and anti-actin (1 : 2000; Abcam #ab1801). Secondary antibodies were donkey anti-rabbit IRDye 800CW fluorescent antibodies (1 : 20 000; LI-COR #925-32213).
GFP histology
Two weeks following intracranial surgery, HR rats that were injected with either AAV-miR-101a (N = 3) or AAV-GFP (N = 3) were not exposed to behavioural testing, but instead were deeply anesthetized with sodium pentobarbital (150 mg/kg i.p.) and then transcardially perfused with~100 mL of physiological saline followed by~300 mL of 4% paraformaldehyde. Brains were extracted, post-fixed overnight, cryoprotected in 20% sucrose and processed for immunohistochemistry as described in previous studies (Kerman et al., 2006) . Briefly, brains were sectioned coronally on a freezing microtome at a thickness of 40 lm. Sections were washed in phosphate-buffered saline (PBS; pH 7.2); blocked in a PBS solution containing 1% BSA, 1% normal goat serum and 0.3% Triton X-100 for 1 h; and incubated overnight in chicken anti-GFP antibody (1 : 500; Invitrogen A1026) at 4°C. The next day, sections were again washed in PBS, incubated in secondary antibody (1 : 500; goat antichicken IgY, Alexa Fluor 488; Invitrogen A11039) for 2 h at room temperature and mounted on slides and coverslipped using Fluoromount-G (SouthernBiotech, Birmingham, AL, USA). Images were taken using an Olympus BX-UCB microscope (Center Valley, PA, USA) equipped with a motorized stage (96S100-LE; Ludl Electronic Products, Hawthorne, NY, USA), fluorophore-specific fluorescent filter sets and a cooled mono-CCD camera (Orca R2; Hamamtsu, Boston, MA, USA).
Statistical analyses
Data were analysed with PRISM 6.0 software (GraphPad Software, San Diego, CA). qPCR data was analysed by comparing DDCTs, difference of the differences in threshold between the gene of interest and housekeeping gene (Gapdh for mRNA and Snord61 for miRNA) between the two groups. Western blots were analysed using IMAGEJ software (NIH, Bethesda, MD), where band densities were determined using area under the curve of each lane's optical density histogram. Bands for H3K27me3 were normalized to total histone 3, while bands for Ezh2 were normalized to actin; HR/LR, AAV-miR-101a/AAV-GFP and Ezh2 siRNA/Control siRNA groups were compared via one-way unpaired t-test or Welch's corrected t-test when there was a significant difference (P < 0.05) between the variances of the two groups. OFT and EPM data were compared in the same manner. For all tests, significance was set at P < 0.05 and results are presented as mean AE SEM.
Results
HR rats display reduced expression of miR-101a-3p and increased expression of Ezh2 and H3K27me3 in the amygdala compared to LR rats Using a high-throughput sequencing approach, we previously found reduced miR-101a-3p expression in the amygdala of HR rats compared to LRs. miR-101a-3p is a known regulator of PRC2 that represses the function of Ezh2 (Varambally et al., 2008; Friedman et al., 2009) , the histone methyltransferase that mediates gene silencing by trimethylating H3K27 (Fig. 1A ; Cao et al., 2002) . Using qRT-PCR, we confirmed a significant reduction in miR-101a-3p in the amygdala of HR rats compared to LRs (P = 0.0324; Fig. 1B) . Consistent with miR-101a-3p's reported role in repressing translation of Ezh2, we found that while there was no change in Ezh2 mRNA (Fig. 1C) , there was significantly more Ezh2 protein in HR compared to LR amygdala (P = 0.0036; Fig. 1D ). HRs also displayed greater levels of H3K27me3 compared to LRs (P = 0.0002; Fig. 1E ), indicating greater functional output of Ezh2 activity.
Viral-mediated miR-101a overexpression in the amygdala increases HR rats' anxiety-like behaviour A separate cohort of HR rats received intra-amygdala injections of either AAV-miR-101a (to overexpress miR-101a-3p) or AAV-GFP (control) and were tested on two rodent tests of anxiety, the OFT and EPM. On the OFT, there was no difference in total distance moved between the two groups ( Fig. 2A) indicating that the viruses did not differentially affect locomotion. HR rats injected with the miR-101a-overexpressing virus displayed increased time spent in the corners of the OFT (P = 0.0580), a reduction in time spent in the centre (P = 0.0097), and fewer centre entries (P = 0.0015; Fig. 2B-D) compared to the control group. On the EPM, there was also no group difference in total distance moved (Fig. 2E) . AAVmiR-101a-injected HRs spent more time in the closed arms (P = 0.0505), less time in the open arms (P = 0.0241) and had fewer open-arm entries (P = 0.0390; Fig. 2F -H) compared to AAV-GFP-injected rats. These results indicate that overexpressing miR101a in HR rats' amygdala led to increased anxiety-like behaviour across both the OFT and EPM.
Viral expression was confirmed through visualization of GFP for both the AAV-GFP and the AAV-miR-101a viruses (Fig. 3A) . Using qRT-PCR, we confirmed that HRs injected with the AAVmiR-101a virus had greater expression of pre-miR101a (P = 0.0113) and mature miR-101a-3p (P = 0.0023) compared to controls, but did not differ in miR-101a-5p expression. There were no GFP expression differences between the two experimental groups (Fig. 3B-E) . The reason that the AAV-miR-101a construct produced an increase in miR-101a-3p but not miR-101a-5p is likely the same as why miR-101a-3p is abundantly expressed while miR-101a-5p is scarcely expressed in rodent amygdala (Cohen et al., 2016) , either miR-101a-5p is not processed to maturity, highly unstable or rapidly degraded. We also showed that miR-101a overexpression caused a reduction in Ezh2 protein levels (P = 0.0291; Fig. 3F ) and reduced H3K27me3 levels (P = 0.0565; Fig. 3G ), which is consistent with miR-101a's known role in repressing Ezh2 expression and functional output.
Knockdown of Ezh2 increases HR rats' anxiety-like behaviour
To determine whether the anxiogenic effects of miR-101a overexpression in the HR amygdala are mediated through repression of Ezh2 by miR-101a-3p, another group of HR rats received intraamygdalar injections of either an Ezh2 targeting siRNA or a control siRNA. Ezh2 knockdown did not affect behaviour in the OFT, with no group differences in distance moved, time in corners, time in centre or centre entries into the OF (Fig. 4A-D) . On the EPM, there were no differences in total distance moved or time in the closed arms ( Fig. 4E-F) . However, animals that received the Ezh2 siRNA spent less time in the open arms (P = 0.0352) and had fewer openarm entries (P = 0.0297; Fig. 4G-H) . Overall, these data showed that Ezh2 knockdown in the amygdala of HR rats had a weaker anxiogenic effect compared to miR-101a overexpression as it increased anxiety-like behaviour on the EPM, but not the OFT.
Animals were killed 24 h after EPM testing, and knockdown of Ezh2 in the amygdala was confirmed (P = 0.0176; Fig. 5A ). We also showed that Ezh2 knockdown caused a reduction in total H3K27me3 in the amygdala (P = 0.0126; Fig. 5B ).
Discussion
The HR/LR rat lines provide a useful tool for studying genetic and molecular factors that contribute to anxiety-like behaviour. Selective breeding for high vs. low locomotor response to novelty produced the behaviourally distinct HR and LR lines, which differ in a number of behavioural domains, including trait anxiety. LR rats display greater anxiety-like behaviour compared to HRs on several behaviour tests, including the elevated plus maze, open-field test and light-dark box (Stead et al., 2006; Clinton et al., 2014; Cohen et al., 2015; Glover et al., 2015) , and these differences are observable as early as the 25th day of life (Clinton et al., 2011) . As the HR/LR behavioural phenotypes are highly heritable and apparent early in life, our research group has sought to identify genetic and epigenetic factors that shape their behaviour. We recently used nextgeneration sequencing to identify numerous miRNA and mRNA expression differences in the amygdala of HR/LR rats (Cohen et al., 2016) . The miRNA miR-101a-3p emerged as an abundant miRNA in the amygdala that was expressed at significantly higher levels in LR vs. HR rats. Our current study confirmed that HRs exhibit lower miR-101a levels in the amygdala compared to LRs as well as greater levels of Ezh2 and H3K27 (Ezh2's functional output); this is consistent with the notion that LRs' elevated miR-101a-3p levels impinge on PRC2/Ezh2 function and hinder H3K27me3 (relative to HRs). We therefore tested the hypothesis that increasing miR-101a-3p in the Relative optical density HR amygdala would increase their typically low levels of anxietylike behaviour. We found that viral-mediated miR-101a-3p overexpression in the HR amygdala increased their anxiety-like behaviour on the EPM and OFT. Overexpressing miR-101a-3p also reduced levels of its target, the histone methyltransferase Ezh2 and H3K27me3. Using an siRNA approach, we found that direct knockdown of Ezh2 also caused an increase in HRs' anxiety-like behaviour, but to a lesser degree than miR-101a-3p overexpression. 
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Basolateral amygdala 100 μm 100 μm Fig. 3 . Viral-mediated miR-101a-3p overexpression leads to reduced Ezh2 and H3K27me3 levels in the HR amygdala. (A) Viral expression of AAV-miR101a and AAV-GFP in the basolateral amygdala. (B) HR rats that received intra-amygdalar injections of AAV-miR101a showed increased expression of pre-miR101a (P < 0.05) and (C) mature miR-101a-3p (P < 0.01) compared to animals injected with AAV-GFP. (D) There were no differences in miR-101a-5p between AAVmiR101a and AAV-GFP animals. (E) There were no differences in GFP mRNA between AAV-miR101a and AAV-GFP animals. (F) Viral-mediated miR-101a overexpression caused a reduction in Ezh2 protein expression (P < 0.05) and (G) H3K27me3 (P = 0.057) in the amygdala of HR rats. *P < 0.05, **P < 0.01. [Colour figure can be viewed at wileyonlinelibrary.com].
Polycomb group proteins (like the PRC2) play an important role in gene silencing through post-translational modification of histone tails. miR-101a-3p is known to negatively regulate PRC2 by inhibiting translation of multiple PRC2 components including embryonic ectoderm development (Eed), suppressor of zeste (Suz12) and Ezh2, the histone methyltransferase that silences gene expression via trimethylation H3K27 (Varambally et al., 2008; Cao et al., 2010) . PRC2/Ezh2 function is required for a number of developmental processes (Chakrabarty et al., 2007; Marchesi et al., 2014) , including maintaining embryonic and adult stem cells, likely due to its role in repressing developmental transcription factor expression (Pietersen & van Lohuizen, 2008) . Given their roles in stem cell maintenance, miR-101a and Ezh2 have been widely studied in the context of cancer. For instance, miR-101a expression decreases and Ezh2 expression increases during progression of prostate cancer (Varambally et al., 2008) and bladder cancer (Friedman et al., 2009) . The Ezh2 inhibitor tazemetostat is currently undergoing clinical trials to test safety and efficacy in treating several different cancers (Kurmasheva et al., 2016) .
Elevated Plus Maze

Open-field Test
In the brain, Ezh2 has been shown to play a role in neural stem cell differentiation. Ezh2 is expressed at high levels in neural stem cells, and its expression decreases during differentiation into neurons and astrocytes, but not oligodendrocytes (Sher et al., 2008) ; Ezh2 overexpression in astrocytes promotes de-differentiation towards a neural stem cell-like state (Sher et al., 2011) . Conditional Ezh2 knockout in neural stem cells results in mice with impaired spatial learning and memory and contextual fear learning and memory as well as decreased progenitor cell proliferation . While Ezh2 clearly regulates a number of key neurodevelopmental processes (Di Meglio et al., 2013; Neo et al., 2014) , it continues to serve important functions in mature neurons, particularly in regard to cellular plasticity . Morphine exposure causes reduced expression of Bdnf in the ventral tegmental area by recruiting Ezh2 and increasing H3K27me3 at the Bdnf promotor, and Ezh2 overexpression combined with morphine exposure increased animals' conditioned place preference to the drug (Koo et al., 2015) . In the cerebellum, Ezh2 restricts dendrite morphogenesis through H3K27me3-mediated repression of Bdnf (Qi et al., 2014) . Other work shows that Ezh2 expression is sensitive to external stimuli, such as stress (Hunter et al., 2009; Xu et al., 2012) and neural activity, which transiently increases Ezh2 and H3K27me levels (Reynolds et al., 2015; Palomer et al., 2016) . Thus, while Ezh2 has traditionally been considered in the context of cell development and differentiation, recent evidence clearly shows numerous important roles in the adult brain, particularly in the ability of neurons to respond to environmental signals.
While this and other studies have demonstrated the effects of changes in Ezh2 on neurobiology and behaviour, others have reported a necessity to target both Ezh1 and Ezh2. In the striatum, knockout of only Ezh1 or Ezh2 was not sufficient to alter H3K27me3 expression or cause changes in the transcriptome as measured by RNA-Seq (von Schimmelmann et al., 2016) . Importantly, expression of H3K27me3 and mRNA was assessed in these knockout mice at 1 year; thus, it is possible that the non-knocked out Ezh isoform compensated for the knocked out isoform. It is also possible that effects of Ezh isoform knockouts are region dependent, with some regions being more susceptible than others. Expression of Ezh1 and Ezh2 varies greatly across the adult rodent brain (Lein et al., 2007) . Selectively bred HR rats, which are known to display low levels of anxiety-like behaviour, exhibit reduced miR-101a-3p expression together with increased Ezh2 and H3K27me3 levels in the amygdala compared to LRs that characteristically display high levels of behavioural inhibition and anxiety-like behaviour. As Ezh2 maintains expression to varying degrees in mature neurons, astrocytes and oligodendrocytes, it is unclear from our current data which cell type (s) may be contributing to the observed HR/LR differences. In our viral manipulation experiment, miR-101a-3p overexpression was limited to neurons through the use of AAV vectors, which selectively transduct neurons but not glia (Mason et al., 2010; Doherty et al., 2011) , and the Ezh2 knockdown experiment using Accell siRNA technology likely predominantly affected neurons as this tool was previously shown to selectively transduce mature neurons but not glia (Nakajima et al., 2012) . Consequently, the observed anxiogenic effects caused by miR-101a overexpression and Ezh2 suppression are likely the result of alterations in neural function. Future work will determine whether knockdown or inhibition of miR-101a-3p and/or overexpression of Ezh2 in the amygdala can produce anxiolytic effects (either in high anxiety-prone LRs or normative rates). We will also continue to investigate the genetic and epigenetic differences between HR and LR rats that may contribute to their disparate stress-reactive and behavioural phenotypes. Chromatin immunoprecipitation studies will determine differences in genomic binding locations of Ezh2 and H3K27me3 between HRs and LRs. These locations could be compared to changes in Ezh2 and H3K27me3 sites that occur following miR-101a-3p overexpression and/or Ezh2 knockdown. Ultimately, such analyses could potentially identify downstream genes and pathways that are responsible for the miR-101a-3p-and Ezh2-driven changes in anxiety-like behaviour.
It is possible that manipulation of miR-101a-3p and Ezh2 alters other amygdala-dependent behaviours besides anxiety. For example, the amygdala is critical to social behaviour (Felix-Ortiz & Tye, 2014; Hong et al., 2014) and HR/LR rats have been shown to display differences in social behaviour. HR rats spend more time interacting with a novel rat of either gender . Future work should examine whether miR-101a-3p overexpression or Ezh2 knockdown in HR rats reduces social interaction behaviour. Effects of miR-101a-3p and Ezh2 on fear conditioning should also be assessed. Previous work has shown that Ezh2 knockout in the hippocampus produces deficits in contextual fear conditioning . We would predict that miR-101a-3p overexpression or Ezh2 knockdown in the amygdala would produce similar deficits in fear-related learning and memory. An important question that remains to be answered is by what mechanism miR-101a-3p overexpression produces a greater increase in anxiety behaviour than Ezh2 knockdown alone. miR-101a-3p also represses other PRC2 transcripts, such as Suz12 and Eed (Varambally et al., 2008; Cao et al., 2010) . These proteins have been shown to be involved in gene silencing independent of H3K27me3. For example, Eed interacts with histone deacetylases and enhances their catalytic activity (Ai et al., 2017) . Thus, the full effects of miR-101a-3p overexpression may be mediated by repression of multiple functions of the PRC2. However, it is also possible that some anxiogenic effects of miR-101a-3p are mediated by targeting transcripts not related to the PRC2. Some of the non-PRC2 component genes that miR-101a-3p is known to target include Pten (Sachdeva et al., 2011) , Cox2 (Chakrabarty et al., 2007) and Atxn1 (Lee et al., 2008) . It is also likely that mIR-101a-3p has other targets that have yet to be characterized. A high-throughput screening approach to identify a comprehensive list of miR-101a-3p targets in the amygdala of HR rats is required to begin to answer this question. Once determined, the effects of knockdown of individual or groups of genes can be tested systematically. It will be important to keep in mind that it may take simultaneous repression of multiple targets in order to fully recapitulate the effects of miR-101a-3p overexpression, as it was recently demonstrated that the effect of miR101 inhibition on neural circuit excitability required simultaneous de-repression of three different transcripts (Lippi et al., 2016) .
In conclusion, viral-mediated miR-101a-3p overexpression in the amygdala of low-anxiety HR rats increases their anxiety-like behaviour and reduces Ezh2 and H3K27me3 levels. Direct Ezh2 knockdown also increases anxiety-like behaviour, but not to the same extent as miR-101a-3p overexpression. Thus, increasing the expression of miR-101a-3p in the amygdala produces an anxiogenic effect that is at least partially mediated via the repression of Ezh2 and its functional output, H3K27me3. Overall, these studies point to a novel molecular mechanism that may contribute to individual differences in anxietylike behaviour. They also add to the growing body of evidence supporting a role for mechanisms once considered to be exclusive to development and differentiation, such as miRNA and epigenetic regulation, in the adult brain and in underlying behavioural phenomena.
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